Investment in oral insulin firm could aid entry to lucrative China market
Oral insulin developer Oramed Pharmaceuticals is looking at China’s growing diabetes problem following a $5m investment from Guangxi Wuzhou Zhongheng.
Oral insulin developer Oramed Pharmaceuticals is looking at China’s growing diabetes problem following a $5m investment from Guangxi Wuzhou Zhongheng.
Meda has terminated a manufacturing contract with Recipharm which says a facility in Sweden and up to 60 jobs could be at threat.
Veeva Systems has launched the European version of its database of doctors and healthcare organisations in Barcelona, Spain
Pfizer scientists wont have to run track, just share data to help catch sports cheats who use candidate drugs to enhance performance according to the World Anti-Doping Authority (WADA).
From CPHI India 2014
The World Health Organisation says its prequalification scheme gives free help to makers of selected APIs, drugs and vaccines who want to boost their standards and access international markets.
A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build a manufacturing facility in the Netherlands.
CRO industry group ACRO has welcomed a US NIH draft policy promoting use of a single IRB for site reviews per institute-backed multi-centre study, arguing that the approach would accelerate trials without compromising safety.